Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-049585
Filing Date
2025-05-15
Accepted
2025-05-15 17:10:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5528
  Complete submission text file 0001104659-25-049585.txt   7127
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Subject) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92925 | Film No.: 25955285
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O WARBY PARKER INC. 233 SPRING STREET, 6TH FLOOR NEW YORK NY 10013
Business Address
Gilboa David Abraham (Filed by) CIK: 0001883353 (see all company filings)

Type: SCHEDULE 13G/A